Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Cited by (1,007)

Items 401–500 of 1,007

1. The Implications of Blood Transfusions for Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
   Xin Yang, Karen P. Alexander, Anita Y. Chen, Matthew T. Roe, Ralph G. Brindis, Sunil V. Rao, W. Brian Gibler, E. Magnus Ohman, Eric David Peterson · 2005 · Journal of the American College of Cardiology
2. The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel’s active metabolite
   Atsuhiro Sugidachi, Taketoshi Ogawa, Atsushi Kurihara, Katsunobu Hagihara, Joseph A. Jakubowski, Masami Hashimoto, Yoichi Niitsu, Fumitoshi Asai · 2007 · Journal of Thrombosis and Haemostasis
3. Improving the Care of Patients with Non-ST-elevation Acute Coronary Syndromes in the Emergency Department: The CRUSADE Initiative
   James W. Hoekstra, Charles V. Pollack, Matthew T. Roe, Eric David Peterson, Ralph G. Brindis, Robert A. Harrington, Robert H. Christenson, Sidney C. Smith, E. Magnus Ohman, W. Brian Gibler · 2002 · Academic Emergency Medicine
4. Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial
   Benjamin M. Scirica, Marc P. Bonaca, Eugene Braunwald, Gaetano Maria De Ferrari, Daniel Isaza, Basil S. Lewis, Felix B. Mehrhof, Piera Angelica Merlini, Sabina A. Murphy, Marc Steven Sabatine et al. · 2012 · The Lancet
5. Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: Results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial
   Adam B. Greenbaum, Cindy Lee Grines, John A. Bittl, Richard Clinton Becker, Dean J. Kereiakes, Ian C. Gilchrist, Jane A. Clegg, Jill E. Stankowski, Donna Roy Grogan, Robert A. Harrington et al. · 2006 · American Heart Journal
6. Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
   Davide Capodanno, Roxana Mehran, Marco Valgimigli, Usman Baber, Stephan Windecker, Pascal Vranckx, George Dangas, Fabiana Rollini, Takeshi Kimura, Jean‐Philippe Collet et al. · 2018 · Nature Reviews Cardiology
7. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures
   Andrew Veitch, Trevor P Baglin, AH Gershlick, S M Harnden, Richard Tighe, Stuart R Cairns · 2008 · Gut
8. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
   Bhatt, Deepak L, Steg, Philippe Gabriel, Mehta, Shamir R, Leiter, Lawrence A, Simon, Tabassome, Fox, Kim, Held, Claes, Andersson, Marielle, Himmelmann, Anders, Ridderstråle, Wilhelm et al. · 2019 · The Lancet
9. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
   2004 · Circulation
10. Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel
    Xiling Jiang, Snehal Samant, Lawrence J. Lesko, Stephan Schmidt · 2015 · Clinical Pharmacokinetics
11. Variable Platelet Response to Aspirin and Clopidogrel in Atherothrombotic Disease
    Andrew O Maree, Desmond J. Fitzgerald · 2007 · Circulation
12. 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy
    Shamir R. Mehta, Kevin R. Bainey, Warren J. Cantor, Marie Lordkipanidzé, Guillaume Marquis‐Gravel, Simon D. Robinson, Matthew Sibbald, Derek Y F So, Graham Christopher Wong, Joseph G. Abunassar et al. · 2017 · Canadian Journal of Cardiology
13. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies
    Voulgari, Nikolaοs Tentolouris, Dimitrios E Papadogiannis · 2010 · Vascular Health and Risk Management
14. Effect of Cytochrome P450 Polymorphisms on Platelet Reactivity After Treatment With Clopidogrel in Acute Coronary Syndrome
    Corinne Frère, Thomas Cuisset, Pierre‐Emmanuel Morange, Jacques Quilici, Laurence Camoin‐Jau, Noémie Saut, Dorothée Faille, Marc Lambert, Irène Juhan-Vague, Jean‐Louis Bonnet et al. · 2008 · The American Journal of Cardiology
15. Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation
    Yukiko Matsumura‐Nakano, Satoshi Shizuta, Akihiro Komasa, Takeshi Morimoto, Hisaki Masuda, Hiroki Shiomi, Koji Goto, Kentaro Nakai, Hisashi Ogawa, Atsushi Kobori et al. · 2019 · Circulation
16. Aspirin Resistance and Atherothrombotic Disease
    Peter John Mason, Alice K. Jacobs, Jane E. Freedman · 2005 · Journal of the American College of Cardiology
17. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting
    LiQian Chen, Arthur Bracey, Rajko Radovancevic, John R. Cooper, Charles D. Collard, William K. Vaughn, Nancy A. Nussmeier · 2004 · Journal of Thoracic and Cardiovascular Surgery
18. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial
    Daniel P. Lindholm, Christoph Varenhorst, Christopher Paul Cannon, Robert A. Harrington, Anders Himmelmänn, Juan Francisco Maya, Steen Husted, Philippe Gabríel Steg, Jan Hein Cornel, Robert F. Storey et al. · 2014 · European Heart Journal
19. Major noncardiac surgery following coronary stenting: When is it safe to operate?
    Arvind K. Sharma, Andrew Edward Ajani, Shadi M. Hamwi, Parimal B. Maniar, Shilen V. Lakhani, Ron Waksman, Joseph M Lindsay · 2004 · Catheterization and Cardiovascular Interventions
20. Soluble CD40 ligand induces β 3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling
    K. S. Srinivasa Prasad, Patrick André, Ming-Shan He, Ming Bao, Jeanne M. Manganello, David R. Phillips · 2003 · Proceedings of the National Academy of Sciences
21. Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease
    Francesco Dentali · 2007 · Archives of Internal Medicine
22. Peripheral arterial disease: identification and implications.
    E. Mohler · 2003 · Archives of Internal Medicine
23. Platelet Function in Patients with Diabetes Mellitus: From a Theoretical to a Practical Perspective
    Nikolaos Kakouros, Jeffrey J. Rade, Antonios Kourliouros, Jon R. Resar · 2011 · International Journal of Endocrinology
24. Antithrombotic Therapy for Coronary Artery Disease
    Robert A. Harrington, Richard Clinton Becker, Michael D. Ezekowitz, T W Meade, Christopher M. O’Connor, David A. Vorchheimer, Gordon Henry Guyatt · 2004 · CHEST Journal
25. ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome
    Corinne Frère, Thomas Cuisset, Jacques Quilici, Laurence Camoin‐Jau, Joseph Carvajal, Pierre‐Emmanuel Morange, Marc Lambert, Irène Juhan-Vague, Jean‐Louis Bonnet, Marie‐Christine Alessi · 2007 · Thrombosis and Haemostasis
26. Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel
    Jung‐Won Suh · 2006 · Canadian Medical Association Journal
27. Mortality Benefit With Prasugrel in the TRITON–TIMI 38 Coronary Artery Bypass Grafting Cohort
    Peter K. Smith, Lawrence T. Goodnough, Jerrold H. Levy, Robert S. Poston, Mary A. Short, Govinda J. Weerakkody, LeRoy A. LeNarz · 2012 · Journal of the American College of Cardiology
28. Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients
    Tullio Palmerini, Diego Della Riva, Umberto Benedetto, Maria Letizia Bacchi Reggiani, Fausto Feres, Alexandre Abizaid, Martine Gilard, Marie‐Claude Morice, Marco Valgimigli, Myeong‐Ki Hong et al. · 2016 · European Heart Journal
29. New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis
    Oldgren, J., Wallentin, L., Alexander, J. H., James, S., Jonelid, B., Steg, G., Sundstrom, J. · 2013 · European Heart Journal
30. Clopidogrel non-responsiveness and risk of cardiovascular morbidity
    Rossella Marcucci, Anna Maria Gori, Betti Giusti, Rosanna Abbate, Gian Franco Gensini, Francesco Sofi · 2010 · Thrombosis and Haemostasis
31. The HDL proteome in acute coronary syndromes shifts to an inflammatory profile
    Khalid Al-Waili, Dana Bailey, Zuhier Ahmed Awan, Swneke Donovan Bailey, Isabelle L. Ruel, Anouar Hafiane, Larbi Krimbou, Sylvie LaBoissière, Jacques J. Genest · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
32. A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study
    Dominick Joseph Angiolillo, Piera Capranzano, Shinya Goto, M. Aslam, B. Desai, Ronald K. Charlton, Yoshi Suzuki, Lyndon C. Box, Steven B. Shoemaker, Martin M. Zenni et al. · 2008 · European Heart Journal
33. Clopidogrel Resistance
    Stephen D. Wiviott, Elliott Marshall Antman · 2004 · Circulation
34. Unanswered Questions for Management of Acute Coronary Syndrome
    Raffaele Bugiardini, Olivia Manfrini, Gaetano Maria De Ferrari · 2006 · Archives of Internal Medicine
35. Recent advances in the diagnosis and treatment of acute myocardial infarction
    Koushik R. Reddy · 2015 · World Journal of Cardiology
36. Randomized Evaluation of the Safety and Efficacy of Enoxaparin Versus Unfractionated Heparin in High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Receiving the Glycoprotein IIb/IIIa Inhibitor Eptifibatide
    Shaun G. Goodman, DAVID H. FITCHETT, Paul W. Armstrong, Mary Tan, Anatoly Langer · 2003 · Circulation
37. Impact of Clopidogrel in Patients With Acute Coronary Syndromes Requiring Coronary Artery Bypass Surgery
    Jeffrey S. Berger, Carla B. Frye, Qing Harshaw, Fred H. Edwards, Steven R. Steinhubl, Richard Clinton Becker · 2008 · Journal of the American College of Cardiology
38. The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial
    Patricia J.M. Best, Steven R. Steinhubl, Peter B. Berger, Arijit Dasgupta, Danielle M. Brennan, Lynda Anne M. Szczech, Robert M. Califf, Eric J. Topol · 2008 · American Heart Journal
39. Risk of Upper Gastrointestinal Bleeding With Low-Dose Acetylsalicylic Acid Alone and in Combination With Clopidogrel and Other Medications
    Luis Alberto García Rodríguez, Kueiyu Joshua Lin, Sonia Hernández–Dı́az, Saga Johansson · 2011 · Circulation
40. Risk of bleeding complications with antiplatelet agents: Meta‐analysis of 338,191 patients enrolled in 50 randomized controlled trials
    Victor L. Serebruany, Alex I. Malinin, Roswith M. Eisert, David C. Sane · 2003 · American Journal of Hematology
41. Chest radiography for the diagnosis of acute aortic syndrome
    Yskert Von Kodolitsch, Christoph Anton Nienaber, Christoph Dieckmann, Ann G. Schwartz, Thomas Hofmann, Caspar Brekenfeld, Volkmar Nicolas, Jürgen Berger, Thomas Meinertz · 2004 · The American Journal of Medicine
42. Loading With 600 mg Clopidogrel in Patients With Coronary Artery Disease With and Without Chronic Clopidogrel Therapy
    Adnan Kastrati, Nicolas von Beckerath, Alexander Joost, Gisela Pogátsa-Murray, Olga Gorchakova, Albert Schömig · 2004 · Circulation
43. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
    Deepak L. Bhatt, Eric J. Topol · 2004 · American Heart Journal
44. Peri-operative management of antiplatelet therapy in patients with coronary artery disease
    Marco Cattaneo, Pierre‐Guy Chassot, Sabine Eichinger, Christian von Heymann, Niklaus Hofmann, Hans Rickli, Michael Spannagl, Bernhard Ziegler, Freek W.A. Verheugt, Kurt Huber et al. · 2011 · Thrombosis and Haemostasis
45. Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y12 receptor antagonist, in healthy subjects
    Renli Teng, Kathleen A. Butler · 2010 · European Journal of Clinical Pharmacology
46. Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques
    Pierre Amarenco, Stephen M. Davis, Elizabeth F. Jones, Ariel A. Cohen, Wolf‐Dieter Heiss, Markku Kaste, Cédric Laouenan, Dennis Young, Malcolm Robert Macleod, Geoffrey Alan Donnan et al. · 2014 · Stroke
47. Antiplatelet therapy: in search of the 'magic bullet'
    Shaun P. Jackson, Simone M. Schoenwaelder · 2003 · Nature Reviews Drug Discovery
48. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
    John A. Bittl, Usman Baber, Steven M. Bradley, Duminda Nalaka Wijeysundera · 2016 · Journal of the American College of Cardiology
49. High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial
    ANDERS G. OLSSON, Gregory G. Schwartz, Michael J. Szarek, William J. Sasiela, Michael D. Ezekowitz, Peter Ganz, Michael F. Oliver, David D. Waters, Andreas Michael Zeiher · 2005 · European Heart Journal
50. Time and Cardiac Risk of Surgery after Bare-metal Stent Percutaneous Coronary Intervention
    Gregory A. Nuttall, Michael J. Brown, John W. Stombaugh, P Michon, Matthew F. Hathaway, Kevin C. Lindeen, Andrew C. Hanson, Darrell R. Schroeder, William C. Oliver, David R. Holmes et al. · 2008 · Anesthesiology
51. Acute Clopidogrel Use and Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
    Rajendra H. Mehta, Matthew T. Roe, Jyotsna Mulgund, E. Magnus Ohman, Christopher Paul Cannon, W. Brian Gibler, Charles V. Pollack, Sidney C. Smith, Thomas Bruce Ferguson, Eric David Peterson · 2006 · Journal of the American College of Cardiology
52. Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale
    Ole Fröbert, Bo Lagerqvist, Þórarinn Guðnason, Leif Thuesen, Roger Svensson, Goran K. Olivecrona, Stefan Karl James · 2010 · American Heart Journal
53. Restoring invisible and abandoned trials: a call for people to publish the findings
    Peter Doshi, Kay Dickersin, David Healy, S. Swaroop Vedula, Tom Jefferson · 2013 · BMJ
54. The platelet P2Y12 receptor for adenosine diphosphate: congenital and drug-induced defects
    Marco Cattaneo · 2010 · Blood
55. ADP Receptor P2Y 12 Is Expressed in Vascular Smooth Muscle Cells and Stimulates Contraction in Human Blood Vessels
    Anna‐Karin Wihlborg, Lingwei Wang, Oscar Ö. Braun, Atli Eyjolfsson, Ronny Gustafsson, Tómas Guðbjartsson, David Erlinge · 2004 · Arteriosclerosis Thrombosis and Vascular Biology
56. 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction
    Hani M. Jneid, Daniel Addison, Deepak L. Bhatt, Gregg C. Fonarow, Sana Z Gokak, Kathleen L. Grady, Lee A. Green, Paul A. Heidenreich, P. Michael Ho, Corrine Y. Jurgens et al. · 2017 · Journal of the American College of Cardiology
57. Normalization of platelet reactivity in clopidogrel‐treated subjects
    Gemma Vilahur, Brian G. Choi, Mohammad Urooj Zafar, Juan F. Viles-González, David A. Vorchheimer, Valentı́n Fuster, J J Badimón · 2006 · Journal of Thrombosis and Haemostasis
58. Bleeding Complications Associated With Combinations of Aspirin, Thienopyridine Derivatives, and Warfarin in Elderly Patients Following Acute Myocardial Infarction
    Khaled Buresly, Mark Jeffrey Eisenberg, Xun Zhang, Louise Pilote · 2005 · Archives of Internal Medicine
59. New Anticoagulant Drugs
    Jeffrey I. Weitz, Jack Hirsh · 2001 · CHEST Journal
60. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery
    the American Association for Thoracic Surgery, the Society of Thoracic Surgeons · 2004 · Journal of the American College of Cardiology
61. Cardiovascular drug therapy in the elderly: benefits and challenges
    Fleg, Jerome L., Aronow, Wilbert S., Frishman, William H. · 2011 · Nature Reviews Cardiology
62. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke
    Peter Malcolm Rothwell, Ale Algra, Pierre Amarenco · 2011 · The Lancet
63. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)
    Smith, Sidney C., Jr. · 2019 · PubMed
64. Perioperative management of the bleeding patient
    Kamrouz Ghadimi, Jerrold H. Levy, Ian J. Welsby · 2016 · British Journal of Anaesthesia
65. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: Executive Summary
    Jeffrey L. Anderson, Cynthia D. Adams, Elliott Marshall Antman, Charles R. Bridges, Robert M. Califf, Donald E. Casey, William E. Chavey, Francis M. Fesmire, Judith S. Hochman, Thomas N. Levin et al. · 2007 · Circulation
66. Predictors of Bleeding and Time Dependence of Association of Bleeding With Mortality
    Willibald Hochholzer, Stephen D. Wiviott, Elliott Marshall Antman, Charles F. Contant, Jianping Guo, Robert Patrick Giugliano, Anthony J. Dalby, Gilles Montalescot, Eugene Braunwald M. D · 2011 · Circulation
67. Benefit of Clopidogrel Over Aspirin Is Amplified in Patients With a History of Ischemic Events
    Peter Arthur Ringleb, Deepak L. Bhatt, Alan T. Hirsch, Eric J. Topol, Werner Hacke · 2004 · Stroke
68. Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome
    Gregory G. Schwartz, ANDERS G. OLSSON, Christie Mitchell Ballantyne, P.J. Barter, Ingar Holme, David G. Kallend, Lawrence A. Leiter, Eran Leitersdorf, John J.V. McMurray, Prediman K. Shah et al. · 2009 · American Heart Journal
69. European Resuscitation Council Guidelines for Resuscitation 2015 Section 8. Initial management of acute coronary syndromes
    Nikolaos I Nikolaou, Hans-Richard Arntz, Abdelouahab Bellou, Farzin Beygui, Leo L Bossaert, Alain Cariou, Nicolas Danchin · 2015 · Resuscitation
70. Understanding the Pathophysiology of Ischemic Stroke: The Basis of Current Therapies and Opportunity for New Ones
    Maryam Adenike Salaudeen, Nura Bello, Rabi’u Nuhu Danraka, Maryam L. Ammani · 2024 · Biomolecules
71. Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes
    Andrzej Budaj, John W. Eikelboom, Sweta Mehta, R. Afzal, Susan Chrolavicius, Jean‐Pierre Bassand, Keith A.A. Fox, Lars C. Wallentin, Ron J.G. Peters, Christopher Bull Granger et al. · 2008 · European Heart Journal
72. Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery Disease, and Peripheral Arterial Disease
    Huyen Anh Tran · 2004 · JAMA
73. Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel
    Michel Zabalza, Isaac Subirana, Joan Sala, Carla Lluís-Ganella, Gavin Lucas, Marta Tomás, Rafel Masià, Jaume Marrugat, Ramón Brugada, Roberto Elosúa · 2011 · Heart
74. Drug-Drug Interaction Profiles of Proton Pump Inhibitors
    Ryuichi Ogawa, Hirotoshi Echizen · 2010 · Clinical Pharmacokinetics
75. Randomized Comparison of Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With High Post-Treatment Platelet Reactivity
    Young‐Hoon Jeong, Seung‐Whan Lee, Bong-Ryong Choi, In‐Suk Kim, Myung-Ki Seo, Choong Hwan Kwak, Jin‐Yong Hwang, Seong‐Wook Park · 2009 · Journal of the American College of Cardiology
76. Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate
    Laurent Macchi, Luc P. Christiaens, Séverine Brabant, Nathalie Sorel, Joseph Allal, Gérard Mauco, A. Brizard · 2002 · Thrombosis Research
77. ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
    Neena S. Abraham, Mark Andrew Hlatky, Elliott Marshall Antman, Deepak L. Bhatt, David J. Bjorkman, Craig B. Clark, Curt Daniel Furberg, David A. Johnson, Charles J. Kahi, Loren Laine et al. · 2010 · The American Journal of Gastroenterology
78. Intensifying Platelet Inhibition — Navigating between Scylla and Charybdis
    Deepak L. Bhatt · 2007 · New England Journal of Medicine
79. Aspirin Plus Clopidogrel Therapy Increases Early Venous Graft Patency After Coronary Artery Bypass Surgery
    Ge Gao, Zhe Zheng, Yi Pi, Bin Lü, Jin-guo Lu, Shengshou Hu · 2010 · Journal of the American College of Cardiology
80. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome
    Zihui Xiao, Pierre Théroux · 2004 · Journal of the American College of Cardiology
81. Oral anticoagulants in patients with coronary artery disease
    Anand, Sonia S., Yusuf, Salim · 2003 · Journal of the American College of Cardiology
82. Aspirin Sensitivity
    Raghava R. Gollapudi, Paul S. Teirstein, Donald D. Stevenson, Ronald A. Simon · 2004 · JAMA
83. Short- Versus Long-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
    Tullio Palmerini, Diego Sangiorgi, Marco Valgimigli, Giuseppe Biondi‐Zoccai, Fausto Feres, Alexandre Abizaid, Ricardo Alves da Costa, Myeong‐Ki Hong, Byeong‐Keuk Kim, Yangsoo Jang et al. · 2015 · Journal of the American College of Cardiology
84. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016
    Derek P. Chew, Ian A Scott, Louise Cullen, John Kerswell French, Tom G. Briffa, Philip A. Tideman, Stephen Woodruffe, Alistair Kerr, Maree Branagan, Philip E. Aylward · 2016 · The Medical Journal of Australia
85. Uremic bleeding: Pathophysiology and clinical risk factors
    Avtar S. Sohal, Azim S. Gangji, Mark Andrew Crowther, Darin J. Treleaven · 2005 · Thrombosis Research
86. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes
    Peter Malcolm Rothwell, Alastair Mitchell Buchan, S. Claiborne Johnston · 2006 · The Lancet Neurology
87. Diagnosis and Management of Acute Coronary Syndrome: An Evidence-Based Update
    Jeffrey Smith, Jenna Negrelli, Megha Manek, Emily M. Hawes, A. J. Viera · 2015 · The Journal of the American Board of Family Medicine
88. Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50 trial
    David A. Morrow, Benjamin M. Scirica, Keith A.A. Fox, Gail O. Berman, John T. Strony, Enrico P. Veltri, Marc P. Bonaca, Polly Fish, Carolyn H. McCabe, Eugene Braunwald · 2009 · American Heart Journal
89. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions
    Laura Mauri, Dean J. Kereiakes, Sharon‐Lise T. Normand, Stephen D. Wiviott, David J. Cohen, David R. Holmes, Sripal Bangalore, Donald E. Cutlip, Michael J. Pencina, Joseph M. Massaro · 2010 · American Heart Journal
90. Clopidogrel resistance?
    Paul Alfred Gurbel, Udaya S. Tantry · 2006 · Thrombosis Research
91. Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents
    Marcel M Levi, Elise S. Eerenberg, Pieter Willem Kamphuisen · 2011 · Journal of Thrombosis and Haemostasis
92. Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose Clopidogrel
    Christopher D. Payne, Ying Grace Li, David S. Small, C. Steven Ernest, Nagy A. Farid, Joseph A. Jakubowski, John T. Brandt, Daniel E. Salazar, Kenneth J. Winters · 2007 · Journal of Cardiovascular Pharmacology
93. Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis
    Sammy Elmariah, Laura Mauri, Gheorghe D. Doros, Benjamin Zev Galper, Kelly E O'Neill, Philippe Gabríel Steg, Dean J Kereiakes, Robert W. Yeh · 2014 · The Lancet
94. 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures
    Hani M. Jneid, Daniel Addison, Deepak L. Bhatt, Gregg C. Fonarow, Sana Z Gokak, Kathleen L. Grady, Lee A. Green, Paul A. Heidenreich, P. Michael Ho, Corrine Y. Jurgens et al. · 2017 · Circulation Cardiovascular Quality and Outcomes
95. Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era
    Michel R Hoenig, Jenny A Doust, Constantine N Aroney, Ian A Scott · 2006 · Cochrane Database of Systematic Reviews
96. Long-Term Outcomes in Patients Undergoing Coronary Stenting on Dual Oral Antiplatelet Treatment Requiring Oral Anticoagulant Therapy
    Roberta Rossini, Giuseppe Musumeci, Corrado Lettieri, Maria Molfese, Laurian Mihalcsik, Paola Mantovani, Vasile Sirbu, Theodore A. Bass, Francesco Della Rovere, Antonello Gavazzi et al. · 2008 · The American Journal of Cardiology
97. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)
    F. Piepoli, Massimo · 2017 · International Journal of Behavioral Medicine
98. 1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor
    Zuzana J Motovska, Ota Hlinomaz, Petr Kala, Milan Hromádka, Jiří Knot, Ivo Varvařovský, J Dušek, Jiří Jarkovský, Roman Miklík, Richard Rokyta et al. · 2017 · Journal of the American College of Cardiology
99. ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
    Deepak L. Bhatt, James M. Scheiman, Neena S. Abraham, Elliott Marshall Antman, Francis K.L. Chan, Curt Daniel Furberg, David A. Johnson, Kenneth W. Mahaffey, Eamonn M.M. Quigley, Robert A. Harrington et al. · 2008 · The American Journal of Gastroenterology
100. Leitlinien: Akutes Koronarsyndrom (ACS)
     Christian W. Hamm · 2004 · Zeitschrift für Kardiologie